ENXTBR:ARGXBiotechs
argenx (ENXTBR:ARGX) After Its Zacks Upgrade What Does The Valuation Narrative Say
Zacks recently upgraded argenx (ENXTBR:ARGX) to a Rank #2 rating, citing higher earnings estimates and a constructive earnings outlook. Investors are now evaluating what this upgraded view might mean for the stock.
See our latest analysis for argenx.
argenx shares have pulled back recently, with a 7 day share price return of negative 5.7% and a 30 day share price return of negative 12.37%. However, the 1 year total shareholder return of 21.54% and 5 year total shareholder return of 174.30%...